Implementation of high dose interval vitamin D supplementation in pediatric patients with inflammatory bowel disease receiving remicade
BACKGROUND: Patients who have been diagnosed with Inflammatory Bowel Disease (IBD) present with increased risk of deficient vitamin D levels. Previous studies have demonstrated that these IBD patients who live in areas with lack of sun exposure are especially susceptible to becoming vitamin D defici...
Main Author: | Johansen, Camille E. T. |
---|---|
Other Authors: | Garcia-Diaz, Fernando |
Language: | en_US |
Published: |
2020
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/41274 |
Similar Items
-
High dose interval vitamin D supplementation in pediatric patients with inflammatory bowel disease receiving Remicade
by: Wells, Reeder M.
Published: (2019) -
Serum and fecal biomarkers predict response to Infliximab therapy in pediatric patients with Inflammatory Bowel Disease
by: Kim, Jochebed
Published: (2020) -
THE EXPERIENCE OF REMICADE USAGE IN THE TREATMENT OF RHEUMATOID ARTHRITIS PTS
by: N F Soroka, et al.
Published: (2002-06-01) -
Use of monoclonal antibodies to tumor necrosis factor (the drug remicade) in rheumatoid arthritis: pilot results
by: G V Lukina, et al.
Published: (2003-05-01) -
Remicade® (infliximab): 20 years of contributions to science and medicine
by: Melsheimer R, et al.
Published: (2019-07-01)